Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 6c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q3 EPS of ($1.26), $0.06 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $5.35 million versus the consensus estimate of $12.94 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24